Gene · 5430
Papers4,359
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,359
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic diversity and microevolution in clinical Cryptococcus isolates from Cameroon. | Med Mycol | 2023 | 37952096 | PubTator, text mining | PubMed |
| Leucine Supplementation Improves Diastolic Function in HFpEF by HDAC4 Inhibition. | Cells | 2023 | 37947639 | PubTator, text mining | PubMed |
| Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases. | Genome Med | 2023 | 37946251 | PubTator, text mining | PubMed |
| SGF29 nuclear condensates reinforce cellular aging. | Cell Discov | 2023 | 37935676 | PubTator, text mining | PubMed |
| Structure of the transcribing RNA polymerase II-Elongin complex. | Nat Struct Mol Biol | 2023 | 37932450 | PubTator, text mining | PubMed |
| Heat shock protein DNAJA2 regulates transcription-coupled repair by triggering CSB degradation via chaperone-mediated autophagy. | Cell Discov | 2023 | 37907457 | PubTator, text mining | PubMed |
| eQTL mapping in fetal-like pancreatic progenitor cells reveals early developmental insights into diabetes risk. | Nat Commun | 2023 | 37903777 | PubTator, text mining | PubMed |
| Super enhancer-driven core transcriptional regulatory circuitry crosstalk with cancer plasticity and patient mortality in triple-negative breast cancer. | Front Genet | 2023 | 37900187 | PubTator, text mining | PubMed |
| Tailoring Potential Natural Compounds for the Treatment of Luminal Breast Cancer. | Pharmaceuticals (Basel) | 2023 | 37895937 | PubTator, text mining | PubMed |
| Histone and DNA Methylation as Epigenetic Regulators of DNA Damage Repair in Gastric Cancer and Emerging Therapeutic Opportunities. | Cancers (Basel) | 2023 | 37894343 | PubTator, text mining | PubMed |
| Network-Derived Radioresistant Breast Cancer Target with Candidate Inhibitors from Brown Algae: A Sequential Assessment from Target Selection to Quantum Chemical Calculation. | Mar Drugs | 2023 | 37888480 | PubTator, text mining | PubMed |
| Five New Species of Aureoboletus and Chalciporus (Boletaceae, Boletales) and Their Ethnomycological Aspects. | J Fungi (Basel) | 2023 | 37888297 | PubTator, text mining | PubMed |
| Integrated Meta-Omics Analysis Unveils the Pathways Modulating Tumorigenesis and Proliferation in High-Grade Meningioma. | Cells | 2023 | 37887327 | PubTator, text mining | PubMed |
| SUMO-Activating Enzyme Subunit 1 Is Associated with Poor Prognosis, Tumor Progression, and Radio-Resistance in Colorectal Cancer. | Curr Issues Mol Biol | 2023 | 37886949 | PubTator, text mining | PubMed |
| Interferon induced circRNAs escape herpesvirus host shutoff and suppress lytic infection. | bioRxiv | 2023 | 37886542 | PubTator, text mining | PubMed |
| DDA1, a novel factor in transcription-coupled repair, modulates CRL4CSA dynamics at DNA damage-stalled RNA polymerase II. | Res Sq | 2023 | 37886519 | PubTator, text mining | PubMed |
A conceptual framework for nomenclatural stability and validity of medically important fungi: a proposed global consensus guideline for fungal name changes supported by ABP, ASM, CLSI, ECMM, ESCMID-EFISG, EUCAST-AFST, FDLC, IDSA, ISHAM, MMSA, and MSGERC. | J Clin Microbiol | 2023 | 37882528 | PubTator, text mining | PubMed |
| Morphology, phylogeny and host specificity of two new Ophiocordyceps species belonging to the "zombie-ant fungi" clade (Ophiocordycipitaceae, Hypocreales). | MycoKeys | 2023 | 37881189 | PubTator, text mining | PubMed |
| Transcription factors direct epigenetic reprogramming at specific loci in human cancers. | Front Genet | 2023 | 37876590 | PubTator, text mining | PubMed |
| Allele biased transcription factor binding across human brain regions gives mechanistic insight into eQTLs. | bioRxiv | 2023 | 37873117 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5430/papers?page=15